Korro Bio Files 8-K
Ticker: KRRO · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Korro Bio filed a routine 8-K on Jan 13, 2025. No major news.
AI Summary
Korro Bio, Inc. filed an 8-K on January 13, 2025, reporting other events and financial statements. The company, formerly known as Frequency Therapeutics, Inc. until April 12, 2017, is incorporated in Delaware and headquartered in Cambridge, MA. This filing does not appear to contain specific financial transaction details or material events beyond routine reporting.
Why It Matters
This 8-K filing indicates Korro Bio is meeting its regulatory reporting obligations. Investors should review the full filing for any specific disclosures that might impact the company's valuation or operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, with no indication of significant negative or positive developments.
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- Frequency Therapeutics, Inc. (company) — Former company name
- January 13, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Cambridge, MA (location) — Principal executive offices
- 60 First Street, 2nd Floor, Suite 250 (address) — Business address
- 001-39062 (identifier) — SEC File Number
- 47-2324450 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing for Korro Bio, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of January 13, 2025.
When was Korro Bio, Inc. formerly known by another name?
Korro Bio, Inc. was formerly known as Frequency Therapeutics, Inc., with a date of name change on April 12, 2017.
In which state is Korro Bio, Inc. incorporated?
Korro Bio, Inc. is incorporated in Delaware.
What is the address of Korro Bio, Inc.'s principal executive offices?
The address of Korro Bio, Inc.'s principal executive offices is 60 First Street, 2nd Floor, Suite 250, Cambridge, MA 02141.
What is the SEC file number for Korro Bio, Inc.?
The SEC file number for Korro Bio, Inc. is 001-39062.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2025-01-13 08:18:03
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share KRRO The Nasdaq Capital M
Filing Documents
- d915237d8k.htm (8-K) — 26KB
- d915237dex991.htm (EX-99.1) — 15KB
- d915237dex992.htm (EX-99.2) — 8KB
- g915237ex99_2s1g1.jpg (GRAPHIC) — 171KB
- g915237ex99_2s2g1.jpg (GRAPHIC) — 77KB
- g915237ex99_2s3g1.jpg (GRAPHIC) — 67KB
- 0001193125-25-005020.txt ( ) — 616KB
- krro-20250113.xsd (EX-101.SCH) — 3KB
- krro-20250113_lab.xml (EX-101.LAB) — 18KB
- krro-20250113_pre.xml (EX-101.PRE) — 11KB
- d915237d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Korro Bio, Inc., dated January 13, 2025 99.2 Selected Slides from Corporate Presentation of Korro Bio, Inc., dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORRO BIO, INC. Date: January 13, 2025 By: /s/ Ram Aiyar Name: Ram Aiyar Title: President and Chief Executive Officer